Sign in
4

Changes in Ownership

Oncotelic Therapeutics, Inc. Filed Acc 0001181431-10-047126

Options or other derivatives

  • Chief Scientific Officer acquired 200,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

CHAPLIN DAVID · Chief Scientific Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2010-09-15 Grant or award : show line 1 in the form Stock Option (Right to Buy) +200,000 200,000 D
Loading xslF345X03/rrd286549.xml…